Taisho Pharmaceutical Co Ltd.

TYO:4535 ISIN:JP3442800003

Taisho Pharmaceutical Co Ltd. (TSE: 4535) is Japan's leading producer of over-the-counter (OTC) drugs, and the number two OTC drug manufacturer in the world. Taisho is currently endeavoring to strengthen its independent R&D capabilities in the field of prescription pharmaceuticals, and also aggressively pursuing tie-ups with both Japanese and overseas companies. 
 
   

View in Other Languages

News

Taisho (TYO:4535) Agreed to Buy Bristol-Myers (NYSE:BMY) Asian Assets For US$310M

🕔9/16/2009 3:19:31 PM 4153

Japan's Taisho Pharmaceutical Co. Ltd. (TYO:4535) said Wednesday it will buy Bristol-Myers Squibb Co.'s (NYSE:BMY) over-the-counter drug assets worth US$310 million in Asia Pacific (excluding China and Japan).

Read Full Article▸
###

15,242 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 9) (Last 30 Days: 54) (Since Published: 3459) 

Company Data

    Headquarters
  • 3-24-1, Takada, Toshima-ku, Tokyo, 170-8683, JAPAN
    • Telephone
  • +81-3-3985-1111 
    • PresidentAkira Uehara  Principal Sector
  • Drugs & OTC 
    • Principal Industry
  • Pharmaceutical 
    • Established
  • 1928 
    • Listed
  • 1963 
    • Sales
  • JPY 286 Bn 
    • Employees
  • 5,477 
    • Homepage
  • www.taisho.co.jp/outline/index-e.htm